本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东大会召开的时间：2025年9月26日 (二)股东大会召开的地点：西藏拉萨市夺底路14号公司6610会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 公司董事长顿珠朗加先生因公务原因未能出席本次会议，全体董事同意推举董事格桑罗布先生主持，会 议采取现场投票与网络投票相结合的方式，本次会议召集、召开符合《公司法》《上市公司股东会规 则》以及《公司章程》相关规定。 (五)公司董事、监事和董事会秘书的出席情况 1、公司在任董事7人，出席5人，顿珠朗加先生、西虹女士因公务原因未能出席本次会议； 2、公司在任监事3人，出席2人，达瓦扎西先生因公务原因未能出席本次会议； 3、公司董事会秘书胡炳芳女士和公司部分高管通过现场会议方式列席了本次会议；西藏珠穆朗玛律师 事务所见证律师以现场会议方式对本次股东大会进行了见 ...

Group 1 - The company held a temporary board meeting where all five participating directors voted in favor of several key proposals [1][2][3] - The company plans to appoint Jiang Xin and Zhou Yanqi as non-independent directors, pending approval at the first temporary shareholders' meeting in 2025 [1][2] - The company intends to change its name to "Guhan Health Industry Group Co., Ltd." to better reflect its main business and enhance brand recognition [2][3] Group 2 - The company expects to engage in daily operational related transactions with its shareholder's affiliate, Hunan Hengchang Pharmaceutical Group Co., Ltd., with a total transaction amount not exceeding 50 million yuan in 2025 [2][3] - A temporary shareholders' meeting is scheduled for September 22, 2025, to discuss the aforementioned proposals [3][4] - All proposals from the board meeting require approval at the upcoming shareholders' meeting [4]

Core Points - The board of directors of Huludao Zinc Industry Co., Ltd. held its 14th meeting of the 11th session on August 29, 2025, where all members confirmed the accuracy and completeness of the disclosed information [2][3] - The meeting approved the proposal to increase the estimated daily related transactions for the year 2025, with all non-related directors voting in favor [2] Summary by Sections Meeting Details - The meeting was convened in compliance with the Company Law, Securities Law, and the company's articles of association, with 9 out of 9 directors present [2] - The meeting was chaired by Chairman Yu Enyuan [2] Resolutions Passed - The board unanimously approved the proposal regarding the increase of estimated daily related transactions for 2025, with a voting result of 3 in favor, 0 against, and 0 abstentions [2] - The proposal was previously reviewed and approved by the independent directors in a special meeting [2]

Group 1 - The company held its 15th meeting of the second board of directors on June 6, 2025, with all 10 directors present, ensuring compliance with legal and regulatory requirements [1] - The board approved the proposal for additional expected daily related transactions for 2025, which will be submitted to the second extraordinary general meeting of shareholders for review [2][3] - The board also approved the achievement of the vesting conditions for the second vesting period of the 2022 restricted stock incentive plan, allowing 120 eligible participants to vest a total of 1.09884 million shares [3][5] Group 2 - The board approved the proposal to void a total of 0.96591 million shares of restricted stock that were granted but not vested due to performance criteria not being met [6] - The board passed a resolution to amend the company's articles of association to enhance decision-making efficiency, which will also be submitted to the extraordinary general meeting of shareholders for special resolution [7] - The board approved the establishment of a remuneration management system for directors and senior management, which will be reviewed at the upcoming extraordinary general meeting of shareholders [8] Group 3 - The board approved amendments to the independent director system and the accountant selection system, which will also be presented at the extraordinary general meeting of shareholders for review [9] - The company plans to hold the second extraordinary general meeting of shareholders on June 23, 2025, at 14:30 [9][12]

Group 1 - The second meeting of the supervisory board of Xinjiang Li New Energy Co., Ltd. was held on March 15, 2025, with all three supervisors present [1] - The supervisory board approved the annual work report for 2024, which summarizes the board's responsibilities and activities [2] - The supervisory board also approved the 2024 annual report and its summary, confirming that the content is true, accurate, and complete [2][3] Group 2 - The supervisory board approved the internal control evaluation report for 2024, which reflects the company's internal control system's construction and operation [3] - The financial report for 2024 was audited by Zhongxinghua Accounting Firm, and the board approved it [4] - The company expects a revenue of no less than 1 billion yuan for 2025, representing a year-on-year growth of 3.02%, and a profit of no less than 100 million yuan, indicating a growth of 29.73% [4] Group 3 - The supervisory board approved the profit distribution plan for 2024, which complies with relevant regulations [5] - The board discussed the expected related party transactions for 2025, but due to a lack of quorum, no resolution was made [5] - The supervisory board approved a financing limit of up to 20 billion yuan for 2025 for the company and its subsidiaries [6] Group 4 - The supervisory board reviewed the special report on the use of raised funds, confirming compliance with regulations and no misuse of funds [6] - The board approved the two-year audit report, confirming that the financial statements for 2022 and 2023 were prepared in accordance with accounting standards [7][8] - The supervisory board approved the application for issuing REITs with a total scale not exceeding 1.5 billion yuan [9]